HSPA4L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.262000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.828000E-02
Normal-vs-Stage2
6.941000E-01
Normal-vs-Stage3
7.283800E-01
Normal-vs-Stage4
9.801200E-01
Stage1-vs-Stage2
5.466100E-02
Stage1-vs-Stage3
2.716200E-02
Stage1-vs-Stage4
3.635600E-02
Stage2-vs-Stage3
4.672600E-01
Stage2-vs-Stage4
6.607800E-01
Stage3-vs-Stage4
6.119000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.103000E-01
Normal-vs-AfricanAmerican
4.898200E-01
Normal-vs-Asian
7.462600E-01
Caucasian-vs-AfricanAmerican
5.808800E-01
Caucasian-vs-Asian
1.486220E-02
AfricanAmerican-vs-Asian
2.647400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.045600E-01
Normal-vs-Female
6.572600E-01
Male-vs-Female
3.313800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.956400E-01
Normal-vs-Age(41-60Yrs)
4.906200E-01
Normal-vs-Age(61-80Yrs)
7.376800E-01
Normal-vs-Age(81-100Yrs)
6.900200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.702000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.183000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.540400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.708300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.204200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.887600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.731400E-01
Normal-vs-Daily Drinker
6.726600E-01
Normal-vs-Weekly Drinker
7.967800E-01
Normal-vs-Occasional Drinker
4.932400E-01
Normal-vs-Social Drinker
3.182800E-01
Non Drinker-vs-Daily Drinker
2.600400E-01
Non Drinker-vs-Weekly Drinker
8.617600E-01
Non Drinker-vs-Occasional Drinker
1.753820E-01
Non Drinker-vs-Social Drinker
3.434000E-02
Daily Drinker-vs-Weekly Drinker
2.286800E-01
Daily Drinker-vs-Occasional Drinker
5.272300E-02
Daily Drinker-vs-Social Drinker
1.598020E-02
Weekly Drinker-vs-Occasional Drinker
2.424800E-01
Weekly Drinker-vs-Social Drinker
1.103390E-01
Occasional Drinker-vs-Social Drinker
7.418000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.065400E-01
Normal-vs-Grade 2
3.241600E-01
Normal-vs-Grade 3
1.428050E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.645200E-01
Grade 1-vs-Grade 3
4.586400E-01
Grade 1-vs-Grade 4
2.065400E-01
Grade 2-vs-Grade 3
6.095200E-01
Grade 2-vs-Grade 4
3.241600E-01
Grade 3-vs-Grade 4
1.428050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.459800E-01
Normal-vs-NonDiabetic
6.994000E-01
Diabetic-vs-NonDiabetic
9.232600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.227800E-01
Normal-vs-NoPancreatitis
6.853600E-01
Pancreatitis-vs-NoPancreatitis
7.752000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.293600E-01
Normal-vs-N1
6.900800E-01
N0-vs-N1
4.318600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.072800E-01
Normal-vs-TP53-NonMutant
2.946000E-01
TP53-Mutant-vs-TP53-NonMutant
7.202400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
